Avenue Therapeutics, Inc.

is a specialty pharmaceutical company that acquires/in-licenses, develops and commercializes products principally for use in the acute/hospital setting.

read more >

Product Pipeline

IV Tramadol

Avenue’s initial product candidate is an intravenous (“IV”) formulation of tramadol HCI for the treatment of moderate to moderately severe post-operative pain.

read more >